Comparison Between Marijuana Smoked in Cigarette Paper Versus Cigar Paper
Launched by NEW YORK STATE PSYCHIATRIC INSTITUTE · Sep 7, 2006
Trial Information
Current as of September 26, 2025
Completed
Keywords
ClinConnect Summary
There has been a rapid increase in marijuana use during the 1990s, with the most recent generation often smoking marijuana in the form of 'blunts' as opposed to more traditional routes such as in pipes or in cigarette paper. A blunt is made by removing the tobacco from a cigar and replacing it with marijuana (Golub and Johnson, 1999). The cigar wrapper contains tobacco and nicotine, which may interact with the cardiovascular and subjective effects of the marijuana to produce a different set of effects and risks than cigarette paper. Anecdotally, marijuana smokers report that blunts are more...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Current blunt marijuana use (minimum of twice/week) drug screen
- • 21-45 years of age
- • Practicing an effective form of birth control (condoms, diaphragm, birth control pill, IUD)
- Exclusion Criteria:
- • Current, repeated illicit drug use(excluding marijuana)
- • Heavy cigarette use (\> 10 cigarettes/day)
- • Presence of significant medical illness (e.g., diabetes, cardiovascular disease, hypertension)
- • Laboratory tests outside normal limits that are clinically unacceptable to the study physician (BP \> 140/90; hematocrit \< 34 for women, \< 36 for men)
- • Significant adverse reaction to marijuana
- • Current parole or probation
- • Pregnancy or current lactation
- • History of significant violent behavior
- • Major current Axis I psychopathology(e.g., mood disorder with functional impairment or suicide risk, anxiety disorder, schizophrenia)
- • History of heart disease
- • Current use of any over-the-counter or prescription
About New York State Psychiatric Institute
The New York State Psychiatric Institute (NYSPI) is a leading research organization dedicated to advancing the understanding and treatment of mental health disorders. Affiliated with Columbia University, NYSPI integrates clinical research with cutting-edge scientific inquiry to develop innovative therapeutic strategies and improve patient care. With a focus on a wide range of psychiatric conditions, NYSPI conducts clinical trials that aim to translate findings from laboratory research into effective interventions, enhancing the quality of life for individuals affected by mental illness. Committed to ethical research practices and collaboration, NYSPI plays a pivotal role in shaping the future of psychiatric care through rigorous scientific exploration and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
Margaret Haney, Ph.D.
Principal Investigator
New York State Psychiatric Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials